Evaluation of a new transdermal testosterone dosage used for 60 days prior to controlled ovarian stimulation in poor responders: preliminary results
Human Reproduction Archives · 2022 · 37 · e000222
DOI: 10.4322/hra.000222 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction Archives, 2022. Verfasst von Paula Luiza Muzetti De Chico und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Chico, P. L. M. D., Giorgi, V. S. I., Ferriani, R. A., & Navarro, P. A. (2022). Evaluation of a new transdermal testosterone dosage used for 60 days prior to controlled ovarian stimulation in poor responders: preliminary results. Human Reproduction Archives, 37, e000222. https://doi.org/10.4322/hra.000222
Vancouver
Chico PLMD, Giorgi VSI, Ferriani RA, Navarro PA. Evaluation of a new transdermal testosterone dosage used for 60 days prior to controlled ovarian stimulation in poor responders: preliminary results. Human Reproduction Archives. 2022;37:e000222. doi:10.4322/hra.000222
BibTeX
@article{Chico2022,
author = {Chico, Paula Luiza Muzetti De and Giorgi, Vanessa Silvestre Innocenti and Ferriani, Rui Alberto and Navarro, Paula Andrea},
title = {Evaluation of a new transdermal testosterone dosage used for 60 days prior to controlled ovarian stimulation in poor responders: preliminary results},
journal = {Human Reproduction Archives},
year = {2022},
volume = {37},
pages = {e000222},
doi = {10.4322/hra.000222}
}
EUVIMED